We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Nothing Blocking Generic Copaxone After Judge Denies Teva Injunction Bid
Nothing Blocking Generic Copaxone After Judge Denies Teva Injunction Bid
Mylan and Sandoz need only FDA approval to launch their generic versions of Teva’s blockbuster MS drug Copaxone, after a federal judge refused Teva’s request to block generic entry.